Výsledky vyhledávání - "MARK B. FISHER"

Akademický článek

Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic Findings and Outcomes

Autor: E. Jason Abel, Mark B. Fisher, Surena F. Matin, Ashish M. Kamat, Colin P. Dinney, H. Barton Grossman

Publikováno v: International Brazilian Journal of Urology, Vol 39, Iss 6, Pp 817-822 (2013)

Objectives To evaluate the pathologic findings and outcomes after distal ureterectomy for a retained ureteral segment following incomplete nephroureterectomy for urothelial carcinoma of the renal pelvis or ureter. Materials and Methods After IRB appr

Externí odkaz: https://doaj.org/article/1e21245050134858b50830054a4ec5d4

Zobrazit plný text záznamu

Delayed Ureterectomy after Incomplete Nephroureterectomy for Upper Tract Urothelial Carcinoma: Pathologic Findings and Outcomes

Autor: H. Barton Grossman, Colin P.N. Dinney, E. Jason Abel, Surena F. Matin, Mark B. Fisher, Ashish M. Kamat

Publikováno v: International Brazilian Journal of Urology, Vol 39, Iss 6, Pp 817-822 (2013)
International braz j urol, Volume: 39, Issue: 6, Pages: 817-822, Published: DEC 2013
International braz j urol v.39 n.6 2013
International Braz J Urol
Sociedade Brasileira de Urologia (SBU)
instacron:SBU

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3bc22d48fc0b7aac917d564cb24889
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000600817&lng=en&tlng=en

Zobrazit plný text záznamu

Phase I Trial of Intravesical Recombinant Adenovirus Mediated Interferon-α2b Formulated in Syn3 for Bacillus Calmette-Guérin Failures in Nonmuscle Invasive Bladder Cancer

Publikováno v: Journal of Urology. 190:850-856

Purpose: A phase I trial of intravesical recombinant adenovirus mediated interferon-α2b gene therapy (rAd-IFNα) formulated with the excipient SCH Syn3 was conducted in patients with nonmuscle invasive bladder cancer who had disease recurrence after

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::50a3c24a2f0ba547cc32be538766771a
https://doi.org/10.1016/j.juro.2013.03.030

Zobrazit plný text záznamu

Penoscrotal Extramammary Paget's Disease: The University of Texas M. D. Anderson Cancer Center Contemporary Experience

Autor: Jennifer M. Taylor, Curtis A. Pettaway, Mark B. Fisher, Jane Suh, Victor G. Prieto, Doina Ivan, Tri H. Nguyen, Lance C. Pagliaro, Paul K. Hegarty

Publikováno v: Journal of Urology. 186:97-102

Extramammary Paget's disease is a rare intra-epithelial malignancy that is occasionally associated with an invasive adenocarcinoma component as well as other secondary cancers. We investigated a consecutive series of patients referred for extramammar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbaac1977cb7aff2baffc7183d4b6198
https://doi.org/10.1016/j.juro.2011.02.2685

Zobrazit plný text záznamu

Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon α: possible use as a surrogate marker

Autor: William F. Benedict, Xin-qiao Zhang, Mark B. Fisher, David J. McConkey

Publikováno v: Cancer gene therapy

Adenoviral transduction of human bladder cancer cells with human interferon alpha-2b (Ad-IFN) produces cancer-specific cell death through direct and indirect mechanisms. The indirect mechanisms involve the secreted IFN produced, which kill, IFN prote

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aad4c0be278638f1038e76b930b9cd5
https://doi.org/10.1038/cgt.2009.2

Zobrazit plný text záznamu

Is Vascular Endothelial Growth Factor Modulation a Predictor of the Therapeutic Efficacy of Gefitinib for Bladder Cancer?

Autor: Wassim Kassouf, Teruo Inamoto, Peter C. Black, Mark B. Fisher, David Gallagher, David J. McConkey, Colin P.N. Dinney, Gordon A. Brown, Liana Adam, Tony Luongo, Menashe Bar-Eli

Publikováno v: Journal of Urology. 180:1146-1153

The epidermal growth factor receptor inhibitor gefitinib (Iressa) is currently being studied in patients with bladder cancer and it has significant anti-angiogenic activity. We investigated the relationship between the modulation of vascular endothel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::868d9c4e0865f50e32f5d7cae9e48179
https://doi.org/10.1016/j.juro.2008.05.001

Zobrazit plný text záznamu

Patient opinion of urologists’ reimbursement

Autor: Fernando J. Bianco, Mark B. Fisher, Jeffrey A. Triest

Publikováno v: Urology. 67:250-253

To determine patient assumptions and opinions of the billing and reimbursement process in an urban urologic practice. Healthcare policy and physician reimbursement has been discussed in political and economic forums; however, few studies exist that r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ed3471a6ba1a6913df381a1e52ab3c
https://doi.org/10.1016/j.urology.2005.08.024

Zobrazit plný text záznamu

The Literature Increasingly Supports Expectant (Conservative) Management of Renal Trauma — A Systematic Review

Autor: Mark B. Fisher, Richard A. Santucci

Publikováno v: The Journal of Trauma: Injury, Infection, and Critical Care. 59:491-501

Background The perfect degree of operative intervention in renal trauma is unknown. However, expectant management for most blunt renal trauma is the standard of care, and nonoperative management is increasingly accepted for stab wounds. The best trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a58de3b1deded4925b2f912ff25238f
https://doi.org/10.1097/01.ta.0000179956.55078.c0

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání